PazopanibReversible hypopigmentation: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1732卷 / 1期

关键词：

D O I：

10.1007/s40278-018-55736-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：280 / 280

相关论文

共 50 条

[21] SorafenibSkin hypopigmentation and other toxicities: case report
Reactions Weekly, 2013, 1469 (1) : 37 - 37
[22] TriamcinoloneLinear cutaneous hypopigmentation and atrophy: case report
Reactions Weekly, 2019, 1769 (1) : 411 - 411
[23] ImiquimodVitiligo-like hypopigmentation: case report
Reactions Weekly, 2010, 1287 (1) : 25 - 25
[24] Antineoplastics/betamethasone/calcipotriolSkin hypopigmentation: case report
Reactions Weekly, 2015, 1539 (1) : 45 - 45
[25] ImiquimodFirst report of hypopigmentation following topical application: case report
Reactions Weekly, 2005, 1056 (1) : 10 - 10
[26] DasatinibDiffuse cutaneous hypopigmentation followed by hyperpigmentation: case report
Reactions Weekly, 2015, 1547 (1) : 110 - 110
[27] TriamcinoloneInjection site hypopigmentation, atrophy and telangiectasia: case report
Reactions Weekly, 2019, 1751 (1) : 361 - 361
[28] PazopanibDigestive toxicity and capillary and cutaneous hypopigmentation: case report
Reactions Weekly, 2022, 1902 (1) : 355 - 355
[29] ImatinibHair graying and loss and skin hypopigmentation: case report
Reactions Weekly, 2014, 1495 (1) : 27 - 27
[30] TriamcinoloneAscending hypopigmentation of the forearm following injection: case report
Reactions Weekly, 2010, 1287 (1) : 39 - 39

← 1 2 3 4 5 →